Contrary to economist expectations, the RBA had lifted its cash rate to 4.75%.
Macquarie Group may yet not meet FY11 guidance, but does playing contrarian imply greener pastures ahead?
China has to act on its currency or a conflict with the US will become inevitable, argues Director of the Peterson Institute for International Economics, Fred Bergsten.
Industry observer TradeTech notes spot uranium prices are consolidating as the market remains active.
Longer term consequences, reminds PFP Wealth’s Tim Price, longer term consequences there will be.
A reassessment of the banking outlook following the NAB and ANZ results and the latest credit data, as well as the current political climate.
Operating conditions for Chinese manufacturers improved markedly in October, report HSBC/Markit Economics.
Quarterly earnings for ResMed were better than many in the market had expected, leading to increases to forecasts and continued positive views on the stock.
The October inflation reading by TD Securities suggests inflation might have bottomed in Australia in the September quarter.
By popular request: my take on the QR National float. Plus some other stocks that suffer from similar characteristics.
